Medication info
Jaygaba CR Sustained Release Tablet 150 mg (Pregabalin)

Jaygaba CR Sustained Release Tablet 150 mg (Pregabalin)

Prescription medicationTablet
Ingredient · strength
Pregabalin›70mg / 1 tablet
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
White to slightly yellow, rectangular, film-coated sustained-release tablet
Packaging
30 tablets (6 tablets/PTP x 5)
Approval status
Active

MFDS item code 201900141 · Approved 2019.01.11 · Insurance code 649701840

Summary

Main use
Treatment of peripheral neuropathic pain in adults
Who uses it
Adults · Children
Adult dosage
1. This medicine should be administered once daily after the evening meal. It should be swallowed whole and should not be split, crushed, or chewed. Adults: A starting dose of 150 mg per day may be administered. Based on each patient's response and tolerability, the dose may be increased at weekly intervals to a maximum of 600 mg per day. Discontinuation: Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually, with intervals of at least 1 week. 2. Patients with renal impairment The safety and efficacy of this medicine have not been established in patients with renal impairment. 3. Patients with hepatic impairment The safety and efficacy of this medicine have not been established in patients with hepatic impairment. 5. Older adults (aged 65 years or older) The safety and efficacy of this medicine have not been established in older adults aged 65 years or older.
Children's dosage
4. Pediatric and adolescent patients The safety and efficacy of this medicine have not been established in pediatric and adolescent patients under 19 years of age.

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of peripheral neuropathic pain in adults

  • Peripheral neuropathic pain
View approved original text

This medication is used to relieve pain caused by peripheral neuropathy in adults. Peripheral neuropathic pain occurs due to nerve damage and can cause significant discomfort in daily life. This medication effectively controls such neural pain, thereby improving pain symptoms. Therefore, it helps alleviate neuropathic pain symptoms in adult patients.

Dosage and Administration

Adult dosage

1. This medicine should be administered once daily after the evening meal. It should be swallowed whole and should not be split, crushed, or chewed. Adults: A starting dose of 150 mg per day may be administered. Based on each patient's response and tolerability, the dose may be increased at weekly intervals to a maximum of 600 mg per day. Discontinuation: Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually, with intervals of at least 1 week. 2. Patients with renal impairment The safety and efficacy of this medicine have not been established in patients with renal impairment. 3. Patients with hepatic impairment The safety and efficacy of this medicine have not been established in patients with hepatic impairment. 5. Older adults (aged 65 years or older) The safety and efficacy of this medicine have not been established in older adults aged 65 years or older.

Children's dosage

4. Pediatric and adolescent patients The safety and efficacy of this medicine have not been established in pediatric and adolescent patients under 19 years of age.

Precautions

This medication may increase the risk of suicidal thoughts or behaviors, so if any mood changes or abnormal behavior occur during treatment, it is essential to inform a healthcare professional immediately. Patients with hypersensitivity to this medication should not take it. Diabetic patients may need to adjust the dose of blood sugar control medications due to weight gain after taking this medication. If symptoms of angioedema (swelling of the face, around the mouth, and upper respiratory tract) occur, administration should be discontinued immediately. Elderly patients should exercise caution as symptoms such as dizziness, drowsiness, loss of consciousness, and confusion may occur, and they should avoid hazardous activities until they are accustomed to these effects. Temporary blurred vision or changes in eyesight may occur, which can improve once the medication is discontinued. Before administering this medication alone, caution is advised due to insufficient data regarding the discontinuation of other antiepileptic drugs. Abrupt discontinuation can lead to withdrawal symptoms such as insomnia, headache, nausea, anxiety, diarrhea, depression, and suicidal thoughts, so it should be gradually discontinued under a doctor's guidance. Patients with a history of drug abuse may be at higher risk of abusing this medication, so special attention is necessary. Patients with impaired kidney function may need dose adjustment. Patients with heart disease should be cautious when taking this medication, especially those with congestive heart failure should use it carefully. When used in combination with opioid analgesics, the risk of central nervous system depression increases, so caution is necessary. Patients with respiratory or neurological diseases, kidney impairment, or elderly patients may be at risk of severe respiratory depression and may require dose adjustments. In early pregnancy, there is a risk of congenital malformations in the fetus, so pregnant women should not take this medication, and women of childbearing age should use effective contraception. Women who are breastfeeding should consider stopping breastfeeding or discontinuing the medication, as it may be transmitted through breast milk and affect the infant. While taking this medication, dizziness and drowsiness may occur, so it is essential to avoid driving or operating dangerous machinery. In case of overdose, symptoms such as drowsiness, confusion, depression, and seizures may occur, requiring immediate medical assistance. It should be stored out of reach of children or the elderly and should not be transferred to other containers.

Side effects

  • Suicidal thoughts
  • suicidal behavior
  • depression
  • abnormal changes in mood and behavior
  • angioedema
  • facial swelling
  • swelling around the mouth
  • upper respiratory tract swelling
  • dizziness
  • drowsiness
Show 98 more
  • loss of consciousness
  • confusion
  • mental disorders
  • blurred vision
  • changes in vision
  • insomnia
  • headache
  • nausea
  • diarrhea
  • influenza-like syndrome
  • restlessness
  • pain
  • seizures
  • sweating
  • weight gain
  • constipation
  • dyspepsia
  • nausea
  • dry mouth
  • vomiting
  • peripheral edema
  • bradycardia
  • palpitations
  • itching
  • arthralgia
  • hypoglycemia
  • rhinitis
  • hypertension
  • snoring
  • pulmonary edema
  • tongue swelling
  • toxic epidermal necrolysis
  • urinary retention
  • gynecomastia
  • lethargy
  • fatigue
  • weakness
  • gait abnormalities
  • decreased libido
  • sleep disorders
  • ataxia
  • speech disorders
  • sensory disturbances
  • memory impairment
  • attention disorders
  • bloody stools
  • increased BUN
  • dysuria
  • erectile dysfunction
  • diplopia
  • tinnitus
  • skin disorders
  • worsening of convulsions
  • shock
  • anaphylaxis-like symptoms
  • Stevens-Johnson syndrome
  • erythema multiforme
  • affective disorders
  • confusional state
  • agitation
  • seizures
  • delirium
  • paralysis
  • facial paralysis
  • slow movement
  • Guillain-Barré syndrome
  • discomfort in the head
  • myasthenia
  • feeling of heat
  • deep vein thrombosis
  • pneumonia
  • thalamic infarction
  • osteoarthritis
  • synovial cyst
  • anemia
  • oral sensory disturbance
  • bruising
  • diabetic retinopathy
  • atrial fibrillation
  • sweating
  • thyroid nodule
  • thyroid nodule
  • spinal canal stenosis
  • musculoskeletal discomfort
  • limb discomfort
  • abdominal pain
  • upper abdominal pain
  • eyelid swelling
  • cataract
  • increased alkaline phosphatase
  • ear disorders
  • affective disorders
  • drowsiness
  • confusional state
  • depression
  • agitation
  • restlessness
  • seizures

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent contact with air and kept at a temperature between 1 and 30 degrees Celsius. This storage method ensures the medication's effectiveness is maintained.

Appearance and packaging

Appearance

White to slightly yellow, rectangular, film-coated sustained-release tablet

Package unit

30 tablets (6 tablets/PTP x 5)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.